Biliary Atresia Treatment Market was valued at US$ 910.7 million in 2021 and is expected to exhibit a CAGR of 7.7% during the forecast period 2022 To 2028

Overview:

There are two forms of Biliary Atresia. The fetal form of the disorder is more common and develops during pregnancy. In both cases, the child has no or reduced bile flow to the small intestine. This causes a mild form of jaundice that disappears by the second or third week of the baby’s life. The disease is caused by inflammation of the bile ducts. The disorder usually starts in the ducts outside the liver, however, may progress to the bile ducts inside the liver. In most cases, no symptoms are present, except for jaundice, which is caused by a buildup of bilirubin.

LIMITED TIME OFFER – Hurry Up!!!

Buy Now To Avail Flat 30% Off

Buy This Complete Business Report with Discounted Price @ https://www.coherentmarketinsights.com/insight/buy-now/4779

Market Dynamics:

Increase in the number of biliary atresia cases and growing susceptible geriatric population is expected to propel growth of the global biliary atresia treatment market during the forecast period. For instance, according to the research published by The National Center for Biotechnology Information in July 2021, Taiwan and Japan has higher number of biliary atresia cases of around 1 to 5 in 1000 live births.

However, harmful side effects caused by biliary drugs and lack of skilled professional is some of the middle-income countries is expected to hamper growth of the global biliary treatment market during the forecast period.

Impact of COVID-19:

The global biliary atresia treatment market witnessed an adverse impact of COVID-19 outbreak in China. Due to the virus outbreak, several countries implemented stringent lockdown rules and mobility restrictions. Thus, several pediatric liver research activities faced challenges. Most of the clinical research studying rare diseases were affected due to COVID-19 outbreak. However, relaxation in lockdown regulations and declining number of COVID-19 cases is expected to support growth of the global biliary atresia treatment market during the forecast period.

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4779

Key Takeaways:

• The global biliary atresia treatment Market is expected to grow, with a CAGR of 7.7% over the forecast period due to high demand for new treatment and safe and effective pharmacological treatments. For instance, in January 2019, the U.S. Food and Drug Administration (FDA) granted Orphan Drug designation to Albireo Pharma’s A4250 for biliary atresia treatment.
• Among regions, Asia Pacific is expected to witness significant growth in the global biliary atresia treatment market during the forecast period due to high rate of biliary atresia incidence and prevalence across the region.
• Major players active in the global biliary atresia treatment market are Glenmark Pharmaceuticals, AstraZeneca plc, Alkem Labs, Eisai Co., Ltd., Novartis AG, Mirum Pharmaceuticals, Inc., Albireo Pharma, Inc., and Pfizer Inc.

Reasons to Purchase This Report

• Current and future of Biliary Atresia Treatment Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Disease Type
     • Market Snapshot, By Treatment Type
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunity
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product Launches / Approvals
   • Pipeline analysis
   • Reimbursement Scenario
   • PEST Analysis
   • PORTER’s Analysis
   • Merger, Collaboration and Acquisitions Scenario
4. Global Biliary Atresia Treatment Market– Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply side and Demand Side Analysis
   • Economic Impart
5. Global Biliary Atresia Treatment Market, By Disease Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Type I
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Type II
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Type III
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
6. Global Biliary Atresia Treatment Market, By Treatment Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2017 – 2028
     • Segment Trends
   • Medications
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
       • Bile Acids
       • Antibiotics
       • Corticosteroids
   • Surgery
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
7. Global Biliary Atresia Treatment Market, By Region, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, For Regions, 2017–2028
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Brazil
     • Mexico
     • Argentina
     • Rest of Latin America
   • Europe
     • U.K.
     • Germany
     • France
     • Italy
     • Spain
     • Russia
     • Rest of Europe
   • Asia Pacific
     • • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • GCC
     • Israel
     • Rest of Middle East
   • Africa
     • North Africa
     • Central Africa
     • South Africa

View Press Release: https://www.coherentmarketinsights.com/press-release/biliary-atresia-treatment-market-4038

About Us: